Certain glucose-lowering meds associated with lower risk for COPD exacerbations
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
Daily7d
Inhaled Therapy with Ensifentrine Significantly may Reduce COPD Exacerbations, unravels research
A new study published in the CHEST journal found that ensifentrine, an innovative inhaled therapy, significantly reduces the ...
PharmiWeb10d
Asthma & COPD Drugs Market Share & Forecast 2034
Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...
Your Good Health: Staying on medication for blood clots saved my life
Many people worry about the side effects of anticoagulant drugs like Eliquis or warfarin, but they prevent far more problems ...
Managed Healthcare Executive2d
Trelegy and Breo Offer Incremental Improvement Over Generics
The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...
Healio7d
Phase 1 trial of potential treatment for IPF moves forward ‘without any safety concerns’
No safety concerns emerged in part one of the phase 1 trial assessing CS014, a histone deacetylase inhibitor that has ...
pulmonologyadvisor16h
In COPD, 59% of Patients Worldwide Experience Fatigue
The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...
Mindfulness helps people with COPD manage anxiety, breathlessness, insomnia
A recent study found that participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...
Senores Pharma acquires US rights for COPD drug
The shares of Senores Pharmaceuticals Limited were trading at ₹570.70 up by ₹36.90 or 6.91% on the NSE today at 2.32 pm.